Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay (Q34162721)

31 July 2017

title

Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay (English)

1 reference

31 July 2017

0 references

10

John Collinge

1 reference

31 July 2017

Julie Ann Edgeworth

1

1 reference

31 July 2017

Michael Farmer

2

1 reference

31 July 2017

Anita Sicilia

3

1 reference

31 July 2017

Paul Tavares

4

1 reference

31 July 2017

Jonathan Beck

5

1 reference

31 July 2017

Tracy Campbell

6

1 reference

31 July 2017

Jessica Lowe

7

1 reference

31 July 2017

Simon Mead

8

1 reference

31 July 2017

Peter Rudge

9

1 reference

31 July 2017

Graham S Jackson

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

377

1 reference

31 July 2017

issue

9764

1 reference

31 July 2017

page(s)

487-493

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

31 July 2017

1 reference

7 January 2021

Prion diseases of humans and animals: their causes and molecular basis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

The transmission dynamics of BSE and vCJD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Kuru in the 21st century--an acquired human prion disease with very long incubation periods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Species-barrier-independent prion replication in apparently resistant species

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Prion infectivity in variant Creutzfeldt-Jakob disease rectum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Isolation and characterization of a proteinase K-sensitive PrPSc fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

How to improve the clinical diagnosis of Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Three reported cases of variant Creutzfeldt-Jakob disease transmission following transfusion of labile blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Variant Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

The most infectious prion protein particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Creutzfeldt-Jakob disease with Alzheimer-type A beta-reactive amyloid plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Presymptomatic detection of prions in blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

Ethical considerations in presymptomatic testing for variant CJD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962308-2

7 January 2021

10.1016/S0140-6736(10)62308-2

Identifiers

DOI

1 reference

31 July 2017

1 reference